Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S

Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed for the diagnosis of cervical cancer. Increasing product approvals along with increasing prevalence of cervical cancer in emerging economies are expected to assist the growth of the market during the forecast period. Furthermore, increasing awareness regarding cervical cancer in emerging economies and increasing funding for R&D in diagnosis of cervical cancer are expected to drive growth of the market during the forecast period.
Market Dynamics
The increasing prevalence of cervical cancer is expected to drive the global cervical cancer diagnostic tests market growth during the forecast period. For instance, according to the World Health Organization (WHO), around 570,000 new cases of cervical cancer were diagnosed globally in 2018.
Moreover, according to the World Cancer Research Fund International, cervical cancer is the fourth most common cancer in women. The table below provides the top 10 countries with highest rates of cervical cancer (according to the World Cancer Research Fund International) in 2018:
Rank Country Age Standardized Rate Per 100,000
1 Eswatini 75.3
2 Malawi 72.9
3 Zambia 66.4
4 Zimbabwe 62.3
5 Tanzania 59.1
6 Burundi 57.4
7 Uganda 54.8
8 Lesotho 52.1
9 Madagascar 51.6
10 Cosmos 50.9
Key features of the study:
This report provides in-depth analysis of the global cervical cancer diagnostic tests market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cervical cancer diagnostic tests market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cervical cancer diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical cancer diagnostic tests market
Detailed Segmentation:
Global Cervical Cancer Diagnostic Tests Market, By Test Type:
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
Global Cervical Cancer Diagnostic Tests Market, By Age Group:
Age 20 – 40
Age Above 40
Global Cervical Cancer Diagnostic Tests Market, By Region:
North America
By Test Type
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
By Age Group
Age 20 – 40
Age Above 40
By Country
U.S.
Canada
Latin America
By Test Type
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
By Age Group
Age 20 – 40
Age Above 40
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
By Age Group
Age 20 – 40
Age Above 40
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Test Type
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
By Age Group
Age 20 – 40
Age Above 40
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Test Type
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
By Age Group
Age 20 – 40
Age Above 40
By Country
GCC
Israel
Rest of Middle East
Africa
By Test Type
Pap Smear Test
Colposcopy Test
ECC Test
HPV Test
By Age Group
Age 20 – 40
Age Above 40
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
DYSIS Medical Ltd. *
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Abbott Laboratories
Becton, Dickinson and Company
The Cooper Companies, Inc.
Danaher Corporation
Hoffmann-La Roche AG
Quest Diagnostics
Arbor Vita Corporation
Hologic, Inc.
Zilico Ltd
Qiagen
“*” marked represents similar segmentation in other categories in the respective section.